Related Experiment Video
Updated: Jun 23, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Potential impact of controlling opium use prevalence on future cancer incidence in Iran
Saeed Nemati1,2, Amir Reza Dardashti2, Elham Mohebbi3,4
1Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Background:
The International Agency for Research on Cancer (IARC) recently classified opium consumption as carcinogenic to humans. This study aimed to estimate the potential reduction in incident cancers by 2035 in Iran, which accounts for 42% of global opium consumption, through decreasing opium use prevalence.
Methods:
The population attributable fraction (PAF) of opium-related cancers was projected using national cancer incidence, age- and gender-specific opium use prevalence, relative cancer risks associated with opium use, and annual percentage changes in cancer incidence rates in Iran. Opium-related cancers were defined based on IARC monographs as cancers of lung, larynx, bladder, esophagus, stomach, pancreas, and pharynx. The number of preventable cancer cases under different opium prevalence scenarios was determined by subtracting attributable cases in each year based on current prevalence from those in alternative scenarios.
Findings:
By 2035, an estimated 3,001,421 new cancer cases are expected in Iran, with 904,013 (30.1%) occurring in opium-related sites. Maintaining the current opium prevalence (5.6%) is projected to cause 111,130 new cancer cases (3.7% of all cancers, 12.3% of opium-related). A 10%, 30%, and 50% reduction in opium prevalence could prevent 9,016, 28,161, and 49,006 total incident cancers by 2035 in Iran, respectively. Reducing opium use prevalence by 10%-50% is projected to have the highest impact on lung cancer (prevention of 2,946-15,831 cases), stomach cancer (prevention of 2,404-12,593 cases), and bladder cancer (prevention of 1,725-9,520 cases).
Interpretation:
Our results highlight the significant benefits that can be achieved through effective cancer prevention policies targeting opium use in Iran. Neglecting this risk factor is estimated to pose a significant burden on cancer incidence in the next decade in this population.
Funding:
None.
Insights
Reducing opium use in Iran could prevent thousands of cancer cases by 2035. A 50% decrease in opium prevalence may avert nearly 49,000 incident cancers, particularly lung, stomach, and bladder cancers.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Opium consumption is classified as carcinogenic by the International Agency for Research on Cancer (IARC).
- Iran accounts for a significant portion (42%) of global opium consumption.
- Opium use is a considerable risk factor for several cancer types.
Purpose of the Study:
- To estimate the potential reduction in incident cancers in Iran by 2035.
- To quantify cancer prevention by decreasing opium use prevalence.
- To assess the impact of reduced opium consumption on specific cancer sites.
Main Methods:
- Population attributable fraction (PAF) was used to project opium-related cancers.
- Data included national cancer incidence, age/gender-specific opium use, and relative cancer risks.
- Calculations considered annual changes in cancer incidence rates and different prevalence reduction scenarios.
Main Results:
- An estimated 3,001,421 new cancer cases are projected in Iran by 2035.
- Opium-related cancers are expected to constitute 30.1% of all incident cases.
- Reducing opium prevalence by 10%-50% could prevent 9,016-49,006 cancers, with significant impact on lung, stomach, and bladder cancers.
Conclusions:
- Effective cancer prevention policies targeting opium use can yield substantial benefits in Iran.
- Opium use represents a significant, preventable burden on future cancer incidence.
- Public health interventions aimed at reducing opium consumption are crucial for cancer control.
More Related Videos
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Regulation
Opioid Analgesics: Morphine and Other Natural Cogeners

